| Literature DB >> 28883520 |
Xiuping Lin1, Qinyu Wu2,3, Yuying Yu1, Zhi Liang2, Yonghong Liu1, Lili Zhou4, Lan Tang5, Xuefeng Zhou6.
Abstract
A novel sesquiterpene methylcyclopentenedione, penicilliumin B (1), was obtained from a deep sea-derived fungus Penicillium sp. F00120, together with three known sesquiterpene cyclohexenones (2-4). Penicilliumin B (1), presenting the first example with the sesquiterpene cyclopentenedione skeleton as natural products, was structurally determined by analysis of the NMR and MS spectroscopic data, while the absolute configurations were assigned by single-crystal X-ray experiments. The plausible biosynthetic pathway of the unusual cyclopentenone skeleton of 1 was proposed. Penicilliumin B (1), with low toxicity, was showed significant potential to inhibit the kidney fibrogenic action in vitro, by a mechanism dependent on disruption of oxidative stress, presenting a new type of promising renoprotective agent.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28883520 PMCID: PMC5589727 DOI: 10.1038/s41598-017-11007-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structures of 1–4.
NMR Spectroscopic Data (500 MHz, CDCl3) for Penicilliumin B (1).
| position | δH ( | δC (type) | position | δH ( | δC (type) |
|---|---|---|---|---|---|
| 1 | 0.95 (dt, 12.4, 4.2) 1.60 (br d, 12.4) | 38.5 (CH2) | 12 | 0.74 (s) | 21.5 (CH3) |
| 2 | 1.47 (m) 1.50 (m) | 19.2 (CH2) | 13 | 0.59 (s) | 14.6 (CH3) |
| 3 | 1.16 (dt, 12.9, 4.5) 1.35 (br d, 12.9) | 41.8 (CH2) | 14 | 1.88* 2.02 (dd, 14.5, 10.5) | 29.9 (CH2) |
| 4 | / | 33.6 (C) | 15 | 4.52 (br s), 4.84 (br s) | 108.3 (CH2) |
| 5 | 1.10 (dd, 12.6, 2.6) | 55.3 (CH) | 16 | / | 75.5 (C) |
| 6 | 1.26 (m) 1.72 (m) | 24.3 (CH2) | 17 | / | 203.2 (C) |
| 7 | 1.91* 2.32 (ddd, 11.5, 3.7, 2.5) | 37.9 (CH2) | 18 | / | 160.4 (C) |
| 8 | / | 149.4 (C) | 19 | 6.92 (s) | 142.8 (CH) |
| 9 | 1.89* | 51.3 (CH) | 20 | / | 201.6 (C) |
| 10 | / | 40.0 (C) | 21 | 2.07 (s) | 11.9 (CH3) |
| 11 | 0.84 (s) | 33.4 (CH3) |
*Overlap.
Figure 2Key HMBC1, H-1H COSY and NOESY correlations of 1.
Figure 3X-ray crystallographic structure of 1.
Figure 4Plausible Biosynthetic Pathway of Compounds 1−4.
Figure 5Penicilliumin B (1) inhibits fibrogenic action of high glucose in RMC cells. RMC cells were incubated with D-glucose (25 mM) for 48 h in the absence or presence of different concentrations (0.1, 0.5 μM) of 1. Cell lysates after various treatments as indicated were immunoblotted with antibodies against fibronectin, collagen I and α-tubulin (A). Full-length blots are presented in Supporting Information Figure S2. Graphic presentations of fibronectin (B) and collagen I (C) protein expressions in four groups as indicated. *p < 0.05 vs control (n = 3). †p < 0.05 vs HG alone (n = 3).
Figure 6Penicilliumin B (1) inhibits proliferative action of high glucose in RMC cells. RMC cells were incubated with D-glucose (25 mM) for 48 h in the absence or presence of different concentrations (0.1, 0.5 μM) of 1. Cell lysates after various treatments as indicated were immunoblotted with antibodies against PCNA, c-myc and α-tubulin (A). Full-length blots are presented in Supporting Information Figure S3. Graphic presentations of PCNA (B) and c-myc (C) protein expressions in four groups as indicated. *p < 0.05 vs control (n = 3). †p < 0.05 vs HG alone (n = 3).
Figure 7Penicilliumin B (1) suppresses oxidative stress in RMC cells. RMC cells were incubated with D-glucose (25 mM) for 24 h in the absence or presence of 1 (0.5 μM). NAPDH oxidase subunits of Nox4 and p47phox were analyzed by western blotting (A). Full-length blots are presented in Supporting Information Figure S4. Graphic presentations of Nox4 (B) and p47phox (C) protein expressions in three groups as indicated. *p < 0.05 vs control (n = 3). † p < 0.05 vs HG alone (n = 3).